Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Association between High Antimetabolite Dose Intensity during Maintenance, Toxicities and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): COG-AALL03N1 Report

Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anne Angiolillo, David Dickens, Joseph Neglia, Yaddanapudi Ravindranath, Amanda Muench Termuhlen, F. Lennie Wong, Wendy Landier, Smita Bhatia

Blood (2023) 142 (Supplement 1): 521.

https://doi.org/10.1182/blood-2023-187197

Published: 2023

Journal Articles

Twenty Year Follow up of Survivors of Childhood Acute Lymphoid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS).

Rajen Mody, MD, Douglas Dover, M.Sc., Yutaka Yasui, Ph.D., Stephen Sallan, MD, Leslie Robison, Ph.D., Joseph Neglia, MD

Blood (2006) 108 (11): 1823.

https://doi.org/10.1182/blood.V108.11.1823.1823

Published: 2006

Journal Articles

Outcomes in CCG-2961, a Children’s Cancer Group Phase III Trial for Untreated Acute Myeloid Leukemia (AML).

Beverly J. Lange, MD, Franklin O. Smith, MD, Patricia A. Dinndorf, MD, Carola A.S. Arndt, MD, Dorothy R. Barnard, MD, Kathryn Dusenbery, MD, Steven A. Feig, MD, James H. Feusner, MD, Sandra Luna-Fineman, MD, Joseph Neglia, MD, MPH, Nita L. Seibel, MD, Leonard Sender, MD, Kevin M. Shannon, MD, Margie Weiman, RN, Robert B. Gerbing, MA, Todd A. Alonzo, PhD

Blood (2005) 106 (11): 169.

https://doi.org/10.1182/blood.V106.11.169.169

Published: 2005

Journal Articles

Quality of Life in Survivors of Childhood and Adolescent Acute Myelogenous Leukemia (AML) Does Not Differ by Treatment (Bone Marrow Transplant (BMT) vs. Chemotherapy). A Report from the Children’s Oncology Group (COG).

H. Stacy Nicholson, MD, MPH, Tianni Zhou, PhD, Zhengjia Chen, MS, Kellie Moran, MS, Charles Sklar, MD, Lonnie Zeltzer, MD, Joseph Neglia, MD

Blood (2005) 106 (11): 701.

https://doi.org/10.1182/blood.V106.11.701.701

Published: 2005

Journal Articles

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

Vassilios I. Avramis, Susan Sencer, Antonia P. Periclou, Harland Sather, Bruce C. Bostrom, Lewis J. Cohen, Alice G. Ettinger, Lawrence J. Ettinger, Janet Franklin, Paul S. Gaynon, Joanne M. Hilden, Beverly Lange, Fataneh Majlessipour, Pracad Mathew, Michael Needle, Joseph Neglia, Gregory Reaman, John S. Holcenberg

Blood (2002) 99 (6): 1986–1994.

https://doi.org/10.1182/blood.V99.6.1986

Published: 2002

NARROW

Association between High Antimetabolite Dose Intensity during Maintenance, Toxicities and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): COG-AALL03N1 Report

Twenty Year Follow up of Survivors of Childhood Acute Lymphoid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS).

Outcomes in CCG-2961, a Children’s Cancer Group Phase III Trial for Untreated Acute Myeloid Leukemia (AML).

Quality of Life in Survivors of Childhood and Adolescent Acute Myelogenous Leukemia (AML) Does Not Differ by Treatment (Bone Marrow Transplant (BMT) vs. Chemotherapy). A Report from the Children’s Oncology Group (COG).

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

Email alerts

ASH Publications

American Society of Hematology

Association between High Antimetabolite Dose Intensity during Maintenance, Toxicities and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): COG-AALL03N1 Report

Twenty Year Follow up of Survivors of Childhood Acute Lymphoid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS).

Outcomes in CCG-2961, a Children’s Cancer Group Phase III Trial for Untreated Acute Myeloid Leukemia (AML).

Quality of Life in Survivors of Childhood and Adolescent Acute Myelogenous Leukemia (AML) Does Not Differ by Treatment (Bone Marrow Transplant (BMT) vs. Chemotherapy). A Report from the Children’s Oncology Group (COG).

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only